High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain
Frontiers in Microbiology · 23.01.2026 · 16
DOI: 10.3389/fmicb.2025.1722314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 23.01.2026. Verfasst von Juan Carlos Soto-Debrán und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Aspergillus fumigatus has been designated by the World Health Organization (WHO) as a critical fungal pathogen. Its spores are commonly present in the air and are inhaled daily. Azoles are the first-line treatment for Aspergillus infections, but the emergence of resistance is a growing concern. However, limited data exist on the occurrence of azole-resistant A. fumigatus in the outdoor environment in Spain.
Methods
This study aimed to investigate the prevalence of azole-resistant A. fumigatus isolates in outdoor air at two distinct locations in Madrid. We characterized the isolates using TRESPERG genotyping and examined the underlying molecular mechanisms responsible for azole resistance development.
Results
Azole-resistant A. fumigatus isolates were found in 55% of the 20 air samples collected. Among the 200 A. fumigatus isolates analyzed, 38.5% were azole resistant and were classified into 10 different genotypes. Notably, the TR34/L98H mutation in Cyp51A was found in 77% of the resistant isolates, while 23% showed no mutations in the screened targets ( cyp 51A, cyp 51B, or hmg 1).
Discussion
This study revealed a high prevalence of azole-resistant A. fumigatus in outdoor environmental air, with the TR34/L98H mutation being the main mechanism of azole resistance. A close genetic relationship was observed among the resistant isolates. This research underscores the need for continued monitoring of environmental azole-resistant A. fumigatus isolates and highlights the importance of understanding genetic diversity and resistance mechanisms to develop effective strategies for fungal infection control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
- Air Quality National Reference Laboratory, National Environmental Health Centre, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Microbiology and Parasitology with Basics of Immunology of the Bogomolets National Medical University, Kyiv, Ukraine.
- Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III, Madrid, Spain.
Zitieren
APA
Soto-Debrán, J. C., Sánchez-Íñigo, F. J., Calvo-López, A. B., Alguacil-Cuéllar, L., Hrynzovska, A. A., Mellado, E., García Dos Santos, S., Alcazar-Fuoli, L., & Alastruey-Izquierdo, A. (2026). High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1722314
Vancouver
Soto-Debrán JC, Sánchez-Íñigo FJ, Calvo-López AB, Alguacil-Cuéllar L, Hrynzovska AA, Mellado E, et al. High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain. Frontiers in Microbiology. 2026;16. doi:10.3389/fmicb.2025.1722314
BibTeX
@article{SotoDebrn2026,
author = {Soto-Debrán, Juan Carlos and Sánchez-Íñigo, Francisco Javier and Calvo-López, Alejandro B and Alguacil-Cuéllar, Laura and Hrynzovska, Anastasiia A and Mellado, Emilia and García Dos Santos, Saul and Alcazar-Fuoli, Laura and Alastruey-Izquierdo, Ana},
title = {High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fmicb.2025.1722314}
}
EUVIMED